SCHEMBL30906371

CC[C@H](C)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)O)C(C)C)C(C)C)[C@@H](C)O)C(C)C

nearest known ligand 0.65

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	CALCR	P30988	6/20	0.65

▸	CCKBR	P32239	4/20	0.59

▸	GLP1R	P43220	4/20	0.59

▸	HCRTR1	O43613	1/20	0.59

▸	HCRTR2	O43614	1/20	0.59

▸	CRHR1	P34998	1/20	0.57

▸	CRHR2	Q13324	1/20	0.57

▸	F2	P00734	4/20	0.56

▸	NPY2R	P49146	1/20	0.54

▸	NPY4R	P50391	1/20	0.54

▸	NPY5R	Q15761	1/20	0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30431706	0.92	CALCR (0.66)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL31000925	0.90	CALCR (0.76)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL30423662	0.88	CALCR (0.62)	CALCRCRHR1CRHR2F2
SCHEMBL30906480	0.88	CALCR (0.57)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL30495792	0.88	CALCR (0.69)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL31000939	0.88	CALCR (0.57)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL31182677	0.88	CALCR (0.78)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL30726594	0.88	CALCR (0.73)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL30498570	0.87	CALCR (0.80)	CALCRCCKBRGLP1RHCRTR1HCRTR2
SCHEMBL31014074	0.87	CALCR (0.75)	CALCRCCKBRGLP1RHCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed